14F. Affiliate Organisation Session: Strategies to outsmart Antibiotic Resistance in Gonorrhoea. Developed by WHO
Tracks
Track 6
| Thursday, September 19, 2024 |
| 11:00 AM - 12:30 PM |
| C2.5 |
Details
Chair
Jo-Anne Dillon, IUSTI2024 Congress Co-President
The WHO estimated that in 2020 approximately 82 million new cases of gonorrhoea among adults occurred worldwide. WHO has reported recently high levels of gonorrhoea resistance in certain Regions such as South-East Asia and Western Pacific. These figures exacerbate the challenge of managing these infections, especially with the limited number of drugs currently used and in the pipeline. Furthermore, recent trials have raised concerns about the potential for further resistance development through preventive measures like Doxycycline. This session aims to explore innovative strategies to combat antimicrobial resistance in gonorrhoea by presenting the latest data, diagnostic tools, and treatment options.
Jo-Anne Dillon, IUSTI2024 Congress Co-President
The WHO estimated that in 2020 approximately 82 million new cases of gonorrhoea among adults occurred worldwide. WHO has reported recently high levels of gonorrhoea resistance in certain Regions such as South-East Asia and Western Pacific. These figures exacerbate the challenge of managing these infections, especially with the limited number of drugs currently used and in the pipeline. Furthermore, recent trials have raised concerns about the potential for further resistance development through preventive measures like Doxycycline. This session aims to explore innovative strategies to combat antimicrobial resistance in gonorrhoea by presenting the latest data, diagnostic tools, and treatment options.
Speaker
Dr Ismail MAATOUK
Physician
WHO HQ STIs
Neisseria gonorrhoeae AMR: global perspective
11:00 AM - 11:10 AMBiography
Prof Monica Lahra
Medical Director
WHO CC for STI and AMR NSWHP Microbiology The Prince of Wales Hospital, Randwick
Country updates on emerging gonorrhoea. AMR: data from Australia and China
11:10 AM - 11:20 AMBiography
Monica Lahra is a Senior Staff Specialist Microbiologist NSW Health Pathology, and Conjoint Professor at UNSW. Director of the WHO Collaborating Centre for STI and AMR, she leads a team responsible for surveillance of pathogenic Neisseria spp. nationally and internationally and works with the WHO and partner CCs on the enhanced gonococcal surveillance programme.
Prof Xiaohong Su
Professor
Hospital for Skin Diseases And Institute Of Dermatology, Chinese Academy Of Medical Sciences
Country updates on emerging gonorrhoea. AMR: data from Australia and China
11:10 AM - 11:20 AMBiography
Dr. Xiaohong Su is a Professor at Hospital for Skin Diseases and Institute of Dermatology, Chinese Academy of Medical Sciences. She has been part of the Chinese STD Guidelines Editorial Board. Her current work has focus on clinical management, molecular epidemiology, and antibiotic resistance of gonorrhea and Mycoplasma genitalium infection.
Dr Barbara Van Der Pol
Professor
University of Alabama at Birmingham Heersink School of Medicine
"AMR stewardship. Advanced diagnostic tools for AMR gonorrhoea"
11:20 AM - 11:30 AMBiography
Dr. Van Der Pol is a Professor of Medicine and Public Health at the University of Alabama at Birmingham and the Director of the UAB STD Diagnostics Laboratory. She has been active in the field of the biology, epidemiology and diagnostics of sexually transmitted infections (STI) for more than 40 years. Her behavioral research focuses on delivery, utilization and implementation of new diagnostic technologies. Dr. Van Der Pol currently serves as the President of the International Society for STD Research.
Prof David Lewis
Director
Western Sydney Sexual Health Centre
Evidence for different treatment recommendations in different settings
11:30 AM - 11:40 AMBiography
David is Director of Western Sydney Sexual Health Centre and Professor at the Universities of Sydney and Cape Town. Research interests include antimicrobial resistance and genital ulcer disease. He is member of WHO’s Strategic Technical and Advisory Committee for HIV, viral hepatitis and STIs, a Council member of the International Society for Infectious Diseases and a Past President of IUSTI-World.
Professor Jo-Anne Dillon
Professor
IUSTI2024 Congress Co-President
Strategies for implementing new therapeutics - Moderator
11:40 AM - 12:10 PMBiography
Jo-Anne Dillon’s research interests include the antimicrobial susceptibility, molecular epidemiology, and biology of Neisseria gonorrhoeae. She co-founded the WHO-GASP program and is currently the President of IUSTI. She is a Distinguished Professor at the University of Saskatchewan.
Dr Remco Peters
Medical Officer
World Health Organization
Strategies for implementing new therapeutics - Strategies on introducing novel antibiotics
11:40 AM - 12:10 PMBiography
Dr Peters leads the STI care and treatment programme at the WHO since this year. He has almost 20 years’ experience working as clinician, epidemiologist, and researcher in the STI and HIV fields in low-resource settings across Southern Africa.
Mr Fernando Pascual Martínez
Access Development Lead
Global Antibiotic Research & Development Partnership
Strategies for implementing new therapeutics - Access and conserving new therapeutics
11:40 AM - 12:10 PMBiography
After obtaining Degrees in Pharmacy and Biochemistry, and a Master in Public Health, Fernando joined Médecins Sans Frontières and worked as a consultant to several organizations like the Medicines Patent Pool, UNICEF and WHO. Currently GARDP Access Development Lead supporting product introduction in low- and middle-income countries.
Dr Caroline Perry
Sr Director Clinical Development
GSK
Strategies for implementing new therapeutics - Access and conserving new therapeutics
11:40 AM - 12:10 PMBiography
Prof Magnus Unemo
Senior Researcher, Director
WHO CC for STIs, Örebro University and Örebro University Hospital, Sweden
Strategies for implementing new therapeutics - What is needed in the laboratory?
11:40 AM - 12:10 PMBiography
Director of the global WHO Collaborating Centre for STIs, Örebro, Sweden. Professor at Örebro University, Sweden and Honorary Professor at University College London, UK. Main research: especially N. gonorrhoeae but also, e.g., C. trachomatis, M. genitalium, syphilis. >470 PubMed-indexed international publications and numerous international guidelines and scientific chapters.
Professor Yonatan Grad
Professor of Immunology and Infectious Diseases
Harvard Chan School of Public Health
"Monitoring emerging challenges in AMR gonorrhoea Novel methods for AMR surveillance in the era of DoxyPEP and other emerging STI prevention tools "
12:10 PM - 12:20 PMBiography
Chair
Jo-Anne Dillon
Professor
IUSTI2024 Congress Co-President
